Feb 11, 2026 04:41PM
Jan 14, 2026 07:53AM
Jan 7, 2026 02:25PM
Jan 7, 2026 02:25PM
Dec 21, 2025 04:00AM
Dec 17, 2025 04:28AM
Dec 16, 2025 10:38AM Monte Rosa Therapeutics (GLUE) PT Raised to $26 at Wedbush
Dec 16, 2025 07:01AM
Dec 16, 2025 06:03AM
Nov 10, 2025 02:33AM
Nov 6, 2025 07:06AM
Oct 24, 2025 07:00AM
Sep 15, 2025 12:02PM
Sep 15, 2025 08:16AM Monte Rosa surges premarket on Novartis collaboration deal
Sep 15, 2025 07:01AM
Aug 7, 2025 07:04AM
Jun 10, 2025 07:00AM
May 8, 2025 07:05AM
Apr 28, 2025 07:05AM
Mar 20, 2025 09:39AM
Mar 20, 2025 07:04AM Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue
Jan 10, 2025 07:05AM
Dec 13, 2024 07:00AM
Dec 11, 2024 07:02AM
Dec 5, 2024 07:04AM
Nov 7, 2024 07:23AM
Nov 7, 2024 07:05AM
Oct 28, 2024 02:06PM Monte Rosa Therapeutics (GLUE) options active on 11K contracts with a focus on November 5, 7.5 and 10 puts as share price up 128%
Oct 28, 2024 12:25PM
Oct 28, 2024 07:01AM
Oct 23, 2024 07:07AM
Aug 19, 2024 07:01AM
Aug 8, 2024 07:13AM
Jun 28, 2024 10:41AM
Jun 28, 2024 07:55AM Piper Sandler Reiterates Overweight Rating on Monte Rosa Therapeutics (GLUE)
Jun 27, 2024 07:06AM
Jun 17, 2024 08:10AM
Jun 14, 2024 08:46AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All